Philippe Brantegem
Personalreferent bei ITEOS THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Philippe Brantegem
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
Active Belgian Land Investment NV
 Active Belgian Land Investment NV Real Estate DevelopmentFinance Active Belgian Land Investment NV is a company that develops residential construction projects. The private company is based in Aalst, Belgium. The company was founded in 1995.
1
| Private Company | Real Estate Development | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Philippe Brantegem
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Teva Women's Health, Inc.
 Teva Women's Health, Inc. Pharmaceuticals: MajorHealth Technology Teva Women's Health, Inc. produces a wide range of women’s healthcare products. Its products include oral contraceptives, intrauterine contraception, and hormone therapy treatments for menopause. The company is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Banks/Brokers | Analyst-Equity Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Analyst-Equity | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Graduate Degree | |
| The Catholic University of America | College/University | Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree | |
| ABLYNX | Biotechnology | Corporate Officer/Principal | |
The Children's Health Fund
 The Children's Health Fund Medical/Nursing ServicesHealth Services The Children's Health Fund is a non-profit organization, which engages in the provision of healthcare services for kids. It offers Blue Bus, a pediatric mobile medical clinic that offers curbside checkups and treatments. The firm also supports the Terra Firma project, a program the provides healthcare, mental health support, and legal assistance for unaccompanied immigrant minors. The company was founded by Irwin E. Redlener, Karen B. Redlener, and Paul Simon in 1987 and is headquartered in New York, NY. | Medical/Nursing Services | Director/Board Member | |
Ogeda SA
 Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree | |
| AstraZeneca Diagnostics | Corporate Officer/Principal | ||
| Julius-Maximilians-Universität Würzburg | College/University | Graduate Degree | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Operating Officer Director/Board Member Director/Board Member Founder | |
| JOUNCE THERAPEUTICS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| University of Pennsylvania Medical Center | College/University | Graduate Degree | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA. | Biotechnology | Director/Board Member | |
| ALLOVIR, INC. | Biotechnology | Director/Board Member Chairman | |
Aelin Therapeutics NV
 Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Pharmaceuticals: Major | Chairman | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
| 89BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Rekindle Therapeutics, Inc.
 Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rekindle Therapeutics, Inc. operates as an biotechnology company. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Nextpoint Therapeutics, Inc.
 Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman Director/Board Member Chairman | |
| RAYZEBIO, INC. | Biotechnology | Director/Board Member | |
Bioimpact Capital LLC
 Bioimpact Capital LLC Investment ManagersFinance MPM BioImpact LLC (MPM BioImpact) is a venture capital firm a subsidiary of MPM Bioimpact Inc founded in 1996. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Renagade Therapeutics, Inc. is an American US-based company that aims to overcome the limitations of RNA medicines by applying their comprehensive deliver, code, edit, insert technologies to precisely correct disease on an unprecedented scale. The company has developed a broad portfolio of RNA delivery systems, which profoundly expand the array of addressable diseases. The company's proprietary, synergistic toolkit allows them to precisely deliver, code, edit, and insert RNA medicines to treat any disease, anywhere in the body. Renagade is built on a foundation of proprietary delivery technologies to unlock previously inaccessible cells, reprogramming cells with superior expression using the leading RNA coding platform via joint venture with Orna Therapeutics, enabling curative therapies by permanently correcting defective genes with proprietary technology, and industry-leading all-RNA system to enable exon or large gene insertions as a gene therapy 2.0 platform. Renagade is backed by MPM BioImpact and F2 Ventures, leading financial groups who have supported the development of over 50 products to market. | Biotechnology | Founder Director/Board Member |
Statistik
International
| Vereinigte Staaten | 38 |
| Belgien | 6 |
| Vereinigtes Königreich | 4 |
| Israel | 2 |
| Deutschland | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 7 |
| Commercial Services | 5 |
| Health Services | 2 |
Operativ
| Director/Board Member | 128 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 47 |
| Chairman | 19 |
| Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ansbert Gadicke | 56 |
| Aaron Davis | 19 |
| Ann Rhoads | 19 |
| Matt Roden | 18 |
| Derek DiRocco | 17 |
| David Hallal | 15 |
| Tony Ho | 15 |
| Detlev Biniszkiewicz | 12 |
| Jill DeSimone | 12 |
| Robert Iannone | 11 |
| Priyanka Belawat | 10 |
| Tim van Hauwermeiren | 9 |
| Matthew Call | 9 |
| Michel Detheux | 8 |
| Bronson Crouch | 6 |
- Börse
- Insiders
- Philippe Brantegem
- Unternehmensverbindungen
